Four telehealth bills could be signed into law over the next year by Congress; President Donald Trump mentioned "right-to-try" legislation in a favorable light in his State of the Union speech; the House Energy and Commerce Committee will hold legislation hearings on the opioid crisis February 26.
Four telehealth bills could be signed into law over the next year, which could resolve the issue of how to reimburse Medicare providers and save potentially billions in public funding. Reuters quoted one analyst who said roughly $135 billion of Medicare's annual $675 billion in spending could be done by telehealth. Two issues to be fixed: how to charge across state lines, and getting Medicare to recognize medical consultations that are not face-to-face as the equivalent of a personal visit to a healthcare provider.
President Donald Trump endorsed efforts by Congress to pass so-called “right-to-try” legislation, which would allow access to experimental treatments for patients with terminal conditions. STAT reported the president’s comments in the State of the Union speech were the first about the issue in nearly a year. The Senate passed legislation last fall but the effort has stalled in the House.
The House Energy and Commerce Committee will begin holding legislative hearings on measures to fight the opioid crisis the week of February 26, The Hill reported. The panel said that there will be multiple hearings to consider legislation aimed at fighting opioid use disorder. Earlier this month, the bipartisan National Governors Association called on Congress and the Trump administration to come up with more funding and coordinate on a response to the crisis, the Associated Press reported.
Telephone Follow-Up on Medicare Patient Surveys Remains Critical
January 16th 2025Including a telephone component in Medicare Consumer Assessment of Healthcare Providers and Systems survey administration continues to be valuable because telephone responses comprise a substantial portion of responses for several underserved groups.
Read More
Quantifying the Altruism Value for a Rare Pediatric Disease: Duchenne Muscular Dystrophy
January 14th 2025Altruism values for treatments of rare, severe pediatric diseases have not been estimated. This study found the altruism value for a hypothetical new Duchenne muscular dystrophy treatment to be $80 per year.
Read More
Health Equity & Access Weekly Roundup: January 11, 2025
January 11th 2025ACA enrollment rate hits a milestone, though IRA subsidies may not extend beyond 2025; network adequacy standards fail to translate into efficient access to mental health care for Medicaid enrollees; research examines racial disparities in postpartum hypertension and vaccine uptake.
Read More